Sublingual Nitroglycerine Practices in Patients with Coronary Artery Disease in Australia

Gallagher, R; Belshaw, J; Kirkness, A; Roach, K; Sadler, L; Warrington, D

Sublingual Nitroglycerine Practices in Patients with Coronary Artery Disease in Australia

Gallagher, R Belshaw, J Kirkness, A Roach, K Sadler, L Warrington, D

Permalink

Publisher:: Lippincott Williams & Wilkins
Publication Type:: Journal Article
Citation:: Gallagher Robyn et al. 2010, 'Sublingual Nitroglycerine Practices in Patients with Coronary Artery Disease in Australia', Lippincott Williams & Wilkins, vol. 25, no. 6, pp. 480-486.
Issue Date:: 2010

Closed Access

	Filename	Description	Size
	2009002031OK.pdf		229.08 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Gallagher, R	en_US
dc.contributor.author	Belshaw, J	en_US
dc.contributor.author	Kirkness, A	en_US
dc.contributor.author	Roach, K	en_US
dc.contributor.author	Sadler, L	en_US
dc.contributor.author	Warrington, D	en_US
dc.date.accessioned	2011-02-07T06:24:35Z
dc.date.available	2011-02-07T06:24:35Z
dc.date.issued	2010	en_US
dc.identifier	2009002031	en_US
dc.identifier.citation	Gallagher Robyn et al. 2010, 'Sublingual Nitroglycerine Practices in Patients with Coronary Artery Disease in Australia', Lippincott Williams & Wilkins, vol. 25, no. 6, pp. 480-486.	en_US
dc.identifier.issn	0889-4655	en_US
dc.identifier.other	C1	en_US
dc.identifier.uri	http://hdl.handle.net/10453/13771
dc.description.abstract	Background and Research Objective: Sublingual nitroglycerin (SLNTG) medications are a recommended treatment for people with coronary artery disease (CAD); however, prescription and knowledge may be suboptimal. This study set out to determine how often SLNTG is prescribed and the knowledge and factors associated in patients with CAD. Subjects and Methods: Patients (n = 142) were recruited from cardiac rehabilitation and surveyed regarding SLNTG prescription and key knowledge areas related to SLNTG in those prescribed (n = 89). Multiple regression analysis was used to determine independent predictors of knowledge. Results and Conclusions: Despite having CAD, 37% were not prescribed SLNTG, and of those prescribed, only 43% received related instruction. Knowledge of SLNTG was low at a mean 7.11 (SD, 2.05) points of a possible 14. Most participants (96%) knew to use SLNTG to treat chest pain/discomfort, and no participant described inappropriate symptoms for treatment. Although most patients (80%) knew to have the SLNTG available at all times, only 46% did so in reality. One in 5 participants reported that they would not call an ambulance if chest pain was unrelieved by SLNTG. Participants had more SLNTG knowledge if they were married, were male, and had been instructed about SLNTG and had less knowledge if their hospital discharge diagnosis included angina. The reporting of calling an ambulance for unrelieved symptoms was increased by having more knowledge of SLNTG, but decreased if participants had prior use of SLNTG, were married, or had more comorbidities. Consideration of prescription for SLNTG and related instruction, particularly for their chest-pain action plan, needs to be provided more systematically for patients with CAD.	en_US
dc.publisher	Lippincott Williams & Wilkins	en_US
dc.relation.ispartof	Verified OK	en_US
dc.relation.ispartof	Journal of Cardiovascular Nursing	en_US
dc.relation.isbasedon	http://dx.doi.org/10.1097/JCN.0b013e3181dc82ac	en_US
dc.subject	cangina, chest pain, knowledge, prescription, sublingual glyceryl trinitrate	en_US
dc.subject.classification	Nursing	en_US
dc.title	Sublingual Nitroglycerine Practices in Patients with Coronary Artery Disease in Australia	en_US
dc.type	Journal article
utslib.citation.volume	25	en_US
utslib.citation.number	6	en_US
utslib.location	United States	en_US
utslib.citation.startpage	480	en_US
utslib.citation.endpage	486	en_US
utslib.identifier.org	NMH.Faculty of Nursing, Midwifery and Health	en_US
utslib.for	111000	en_US
utslib.percentage	000100	en_US
utslib.copyright.status	closed_access

Abstract:

Background and Research Objective: Sublingual nitroglycerin (SLNTG) medications are a recommended treatment for people with coronary artery disease (CAD); however, prescription and knowledge may be suboptimal. This study set out to determine how often SLNTG is prescribed and the knowledge and factors associated in patients with CAD. Subjects and Methods: Patients (n = 142) were recruited from cardiac rehabilitation and surveyed regarding SLNTG prescription and key knowledge areas related to SLNTG in those prescribed (n = 89). Multiple regression analysis was used to determine independent predictors of knowledge. Results and Conclusions: Despite having CAD, 37% were not prescribed SLNTG, and of those prescribed, only 43% received related instruction. Knowledge of SLNTG was low at a mean 7.11 (SD, 2.05) points of a possible 14. Most participants (96%) knew to use SLNTG to treat chest pain/discomfort, and no participant described inappropriate symptoms for treatment. Although most patients (80%) knew to have the SLNTG available at all times, only 46% did so in reality. One in 5 participants reported that they would not call an ambulance if chest pain was unrelieved by SLNTG. Participants had more SLNTG knowledge if they were married, were male, and had been instructed about SLNTG and had less knowledge if their hospital discharge diagnosis included angina. The reporting of calling an ambulance for unrelieved symptoms was increased by having more knowledge of SLNTG, but decreased if participants had prior use of SLNTG, were married, or had more comorbidities. Consideration of prescription for SLNTG and related instruction, particularly for their chest-pain action plan, needs to be provided more systematically for patients with CAD.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/13771